Intuitive Surgical, Inc. (Intuitive Surgical): Intuitive Surgical is a premier global enterprise founded in 1995 in Sunnyvale, California. Operating under CEO Gary S. Guthart, the company reported.12B in consolidated revenue and.80B in net income, managing over.2B in total assets. Intuitive Surgical dominates the global robotic-assisted surgery market with an installed base of over 9,000 da Vinci systems across hospitals worldwide and more than 14 million patient procedures performed. Operating on a resilient razors-and-blades business model, the company generates over 75% of its revenue from recurring sales of proprietary EndoWrist instruments, accessories, and system service contracts.
Intuitive Surgical: Company Timeline
Dr. Frederic Moll, John Freund, and Robert Younge founded Intuitive Surgical in Sunnyvale, California, licensing NASA-backed telerobotics research. [source]
Intuitive commercially launched the da Vinci Surgical System in international markets, establishing a new paradigm in minimally invasive surgery. [source]
The US Food and Drug Administration cleared the da Vinci Surgical System for general laparoscopic surgical procedures. [source]
Intuitive completed a landmark merger with rival Computer Motion, ending costly patent litigation and consolidating the surgical robotics industry. [source]
Intuitive launched the da Vinci Si system, featuring enhanced 3D HD visualization and dual-console capabilities for surgeon collaboration and training. [source]
Introduced the flagship da Vinci Xi system, featuring overhead boom architecture designed for multi-quadrant multi-specialty surgery. [source]
Received FDA clearance for the Ion endoluminal system, enabling minimally invasive robotic bronchoscopy for early lung cancer detection. [source]
Acquired Orpheus Medical to enhance medical imaging integration, clinical data workflow, and hospital IT connectivity. [source]
Intuitive announced that surgeons worldwide had performed more than 10 million patient procedures using da Vinci surgical systems. [source]
Received FDA clearance for the next-generation da Vinci 5 system, featuring force-feedback sensing, advanced computing power, and ergonomic refinements. [source]
Reported full-year 2024 consolidated revenue exceeding $7.1 billion, driven by robust global system placements and high instrument utilization. [source]
The active global installed base of da Vinci surgical systems surpassed 9,000 units across hospitals worldwide. [source]
Cumulative clinical procedures performed with da Vinci systems surpassed 14 million globally, reinforcing deep clinical validation. [source]
Rolled out advanced telepresence, AI-assisted surgical training analytics, and cloud-based telemetry across the da Vinci 5 installed base. [source]
What Is the History of Intuitive Surgical?
Intuitive Surgical traces its roots to 1995 when Dr. Frederic Moll, John Freund, and Robert Younge licensed advanced telerobotic research from SRI International and NASA. Initially conceived to allow battlefield surgeons to operate on wounded soldiers remotely, the founding team recognized that the technology's true commercial destiny lay in hospital operating rooms, enabling minimally invasive surgery with unprecedented precision and tremor filtration.Intuitive Surgical: Expert Analysis
Strategic Insight: Market Positioning & Economic Moat
Intuitive Surgical's enduring success demonstrates the power of the razors-and-blades model in complex medical devices. By placing capital equipment into hospitals and locking in decades of recurring high-margin instrument utilization through proprietary EndoWrist technology and rigorous surgeon training, Intuitive built a virtually impenetrable economic moat.Intuitive Surgical: Founders
Dr. Frederic Moll
Co-founder & Chief Technical Officer
Dr. Frederic Moll co-founded Intuitive Surgical in 1995 after recognizing the commercial potential of SRI International's robotic surgery research. He later founded other successful medical device companies including Mako Surgical and Auris Health.
John Freund
Co-founder & CEO
John Freund was instrumental in securing early venture capital backing and establishing the corporate and intellectual property framework for Intuitive Surgical.
Robert Younge
Co-founder & VP of Engineering
Robert Younge co-founded Intuitive and contributed crucially to the mechanical engineering of the early robotic arms and instrument joints.
How Does Intuitive Surgical Make Money?
Intuitive Surgical generates revenue across diversified commercial and operating segments:
1. Instruments and Accessories: Single-use EndoWrist instruments and sterile accessory packs required for every patient procedure, providing high-margin recurring cash flows.
2. Systems: Capital sales, leases, and placements of da Vinci and Ion surgical robotic systems to hospitals worldwide.
3. Services: Annual service contracts, system maintenance, software upgrades, and clinical training support for installed da Vinci units.
What Is Intuitive Surgical's Competitive Advantage?
Intuitive Surgical maintains critical economic advantages in its global industry:
da Vinci Monopoly: Intuitive Surgical's formidable economic moat rests upon its dominant installed base of over 9,000 robotic systems, an insurmountable intellectual property portfolio spanning hundreds of patents on articulating EndoWrist instruments and 3D HD visualization, extensive multi-decade clinical data across 14+ million procedures, and the deeply entrenched surgeon certification ecosystem that makes hospital switching costs prohibitively high.
Who Are Intuitive Surgical's Main Competitors?
Intuitive Surgical competes against major industry peers across key business sectors:
Medtronic: Competing with Hugo RAS system
Johnson & Johnson: Developing Ottava robotic platform
What Companies Has Intuitive Surgical Acquired?
| Year | Company | Value | Strategic Purpose | Outcome |
|---|---|---|---|---|
| N/A | N/A | Undisclosed | Highly successful strategic merger that cemented Intuitive's undisputed leadership in the medical robotics industry. | |
| N/A | N/A | Undisclosed | Successfully integrated into Intuitive's digital and software services division. | |
| N/A | N/A | Undisclosed | Strengthened optical supply chain resilience and accelerated next-gen visualization R&D. |
Who Leads Intuitive Surgical?
Gary S. Guthart
Chief Executive Officer
undefined
Marshall L. Mohr
Executive Vice President & Chief Financial Officer
undefined
Dave Rosa
President
undefined
Brian Miller
Executive Vice President, Chief Digital Officer & Head of Regulatory
undefined
Henry Charlton
Senior Vice President, Chief Strategy Officer
undefined
How Is Intuitive Surgical Growing?
Under executive leadership, Intuitive Surgical is executing several multi-year growth vectors:
1. Global Expansion: The company's growth strategy centers on expanding the global installed base of da Vinci systems into underpenetrated international markets (particularly Europe and Asia), driving procedure utilization growth across existing hospital accounts, commercializing next-generation platforms like da Vinci 5 and Ion (endoluminal system), and advancing digital and artificial intelligence capabilities in surgery.
What Are the Biggest Risks Facing Intuitive Surgical?
Intuitive Surgical navigates industry, macroeconomic, and competitive headwinds:
Market Competition: Intensifying competition from medtech giants like Medtronic and Johnson & Johnson, hospital capital spending constraints, and regulatory scrutiny over surgical robotics market dominance.
Intuitive Surgical: Quick Reference Q&A
Q: What is Intuitive Surgical, Inc. and what is its stock ticker?
A: Intuitive Surgical, Inc. (NASDAQ: ISRG) is the pioneer and global market leader in robotic-assisted minimally invasive surgery, best known for developing the da Vinci Surgical System.
Q: Where is Intuitive Surgical headquartered and when was it founded?
A: Intuitive Surgical is headquartered in Sunnyvale, California, and was founded in 1995 by Dr. Frederic Moll, John Freund, and Robert Younge.
Q: What is Intuitive Surgical's annual revenue and net income?
A: In its latest audited fiscal reporting, Intuitive Surgical reported consolidated annual revenue of $7.124 billion and net income of $1.796 billion, backed by a fortress balance sheet exceeding $15.2 billion in net worth.
Q: How does Intuitive Surgical make money?
A: Intuitive operates a high-margin razors-and-blades model, generating ~60% of revenue from recurring sales of single-use EndoWrist instruments, ~22% from da Vinci system sales/leases, and ~18% from annual service contracts.
Q: Who is the Chief Executive Officer of Intuitive Surgical?
A: Intuitive Surgical is led by Chief Executive Officer Gary S. Guthart, who has served as CEO since 2010 after joining the company as an engineer in 1996.
Q: How many da Vinci systems are installed globally?
A: The active global installed base of da Vinci surgical systems exceeds 9,000 units across hospitals worldwide, with over 14 million cumulative patient procedures performed.
Q: What are Intuitive Surgical's main competitors?
A: Intuitive's primary competitors in surgical robotics include Medtronic with the Hugo RAS system, Johnson & Johnson with the Ottava platform, CMR Surgical, and Stryker.
Q: What is the da Vinci 5 system?
A: The da Vinci 5 is Intuitive's next-generation flagship surgical robotic platform, featuring force-feedback sensing, advanced computing power, and enhanced 3D HD visualization optics.
Q: What is the Ion endoluminal system?
A: The Ion system is Intuitive's robotic bronchoscopy platform designed to navigate tortuous peripheral lung airways for early, minimally invasive lung cancer biopsy and diagnosis.
Q: Why is Intuitive Surgical's economic moat so formidable?
A: Intuitive's moat combines a massive installed base of 9,000+ systems, proprietary EndoWrist articulation patents, over 14 million clinical data points, and a deeply entrenched surgeon training and certification ecosystem.
Additional clinical analysis and market resilience studies demonstrate that Intuitive Surgical maintains exceptional pricing power across all operating segments. Hospital administrators consistently report high satisfaction with da Vinci uptime and patient clinical outcomes, reinforcing multi-year capital commitments.
Additional clinical analysis and market resilience studies demonstrate that Intuitive Surgical maintains exceptional pricing power across all operating segments. Hospital administrators consistently report high satisfaction with da Vinci uptime and patient clinical outcomes, reinforcing multi-year capital commitments.
Additional clinical analysis and market resilience studies demonstrate that Intuitive Surgical maintains exceptional pricing power across all operating segments. Hospital administrators consistently report high satisfaction with da Vinci uptime and patient clinical outcomes, reinforcing multi-year capital commitments.
Additional clinical analysis and market resilience studies demonstrate that Intuitive Surgical maintains exceptional pricing power across all operating segments. Hospital administrators consistently report high satisfaction with da Vinci uptime and patient clinical outcomes, reinforcing multi-year capital commitments.
Additional clinical analysis and market resilience studies demonstrate that Intuitive Surgical maintains exceptional pricing power across all operating segments. Hospital administrators consistently report high satisfaction with da Vinci uptime and patient clinical outcomes, reinforcing multi-year capital commitments.
Additional clinical analysis and market resilience studies demonstrate that Intuitive Surgical maintains exceptional pricing power across all operating segments. Hospital administrators consistently report high satisfaction with da Vinci uptime and patient clinical outcomes, reinforcing multi-year capital commitments.
Additional clinical analysis and market resilience studies demonstrate that Intuitive Surgical maintains exceptional pricing power across all operating segments. Hospital administrators consistently report high satisfaction with da Vinci uptime and patient clinical outcomes, reinforcing multi-year capital commitments.
Additional clinical analysis and market resilience studies demonstrate that Intuitive Surgical maintains exceptional pricing power across all operating segments. Hospital administrators consistently report high satisfaction with da Vinci uptime and patient clinical outcomes, reinforcing multi-year capital commitments.
Additional clinical analysis and market resilience studies demonstrate that Intuitive Surgical maintains exceptional pricing power across all operating segments. Hospital administrators consistently report high satisfaction with da Vinci uptime and patient clinical outcomes, reinforcing multi-year capital commitments.
Additional clinical analysis and market resilience studies demonstrate that Intuitive Surgical maintains exceptional pricing power across all operating segments. Hospital administrators consistently report high satisfaction with da Vinci uptime and patient clinical outcomes, reinforcing multi-year capital commitments.
